Back to Results
First PageMeta Content
Anti-diabetic drugs / Amides / Diabetes / Guanidines / Metformin / Linagliptin / Vildagliptin / Sulfonylurea / Diabetes mellitus type 2 / Chemistry / Organic chemistry / Dipeptidyl peptidase-4 inhibitors


Microsoft WordLinagliptin + Metformin Boerhinger PSD March 2013 FINAL.docx
Add to Reading List

Document Date: 2014-10-01 21:56:23


Open Document

File Size: 87,05 KB

Share Result on Facebook

Company

AEs / The PBAC / Boehringer Ingelheim Pty Ltd / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

Facility

Royal Australian College of General Practitioners / /

IndustryTerm

treatment of diabetes / clinical management algorithm / /

MedicalCondition

vomiting / study Diabetes / diabetes mellitus / Obesity / disease / headache / nasopharyngitis / type 2 diabetes mellitus / diabetes / /

MedicalTreatment

oral therapy / /

Organization

View Authority / Royal Australian College of General Practitioners / Listing Requested and PBAC’s View Authority / /

Position

representative / /

Product

metformin hydrochloride / rosiglitazone / glucagon / Linagliptin tablets / FDC / /

Technology

pharmacokinetics / clinical management algorithm / /

SocialTag